Home › Funds › Parkman Healthcare Partners LLC › MBX
Parkman Healthcare Partners LLC position in MBX
MBX BIOSCIENCES INC · Health Care
Parkman Healthcare Partners LLC reported holding 716,542 shares of MBX (MBX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$42.0M, representing 3.79% of its reported portfolio and ranking #3 among its reported holdings. Parkman Healthcare Partners LLC has disclosed MBX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's MBX position evolved
Parkman Healthcare Partners LLC first disclosed a stake in MBX in Q4 2024 at 170,000 shares (US$3.1M). The position peaked in Q2 2026 at 800,173 shares, worth US$44.2M. Across 8 filings, Parkman Healthcare Partners LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 716,542 shares valued at US$42.0M — a reduction of -83,631 shares quarter over quarter.. Notable position changes include a 93% increase in Q1 2025 (shares rose 55% over the following quarter), a 166% increase in Q2 2025 (shares rose 53% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 170.00K | $3.13M | New |
| Q1 2025 | 328.32K | $2.42M | Add |
| Q2 2025 | 871.93K | $9.95M | Add |
| Q3 2025 | 773.30K | $13.53M | Reduce |
| Q4 2025 | 885.64K | $27.93M | Add |
| Q1 2026 | 800.04K | $23.88M | Reduce |
| Q2 2026 | 800.17K | $44.17M | Hold |
| Q3 2026 | 716.54K | $42.00M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MBX and 13F data
MBX (MBX BIOSCIENCES INC) is a Health Care company. 61 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), Paradigm Biocapital Advisors LP (US$221.2M), NEA Management Company, LLC (US$199.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MBX
- Frazier Life Sciences Management, L.P. 6.65M sh · $367.19M · Q2 2026
- Paradigm Biocapital Advisors LP 3.77M sh · $221.17M · Q3 2026
- NEA Management Company, LLC 3.61M sh · $199.52M · Q2 2026
- ORBIMED ADVISORS LLC 3.43M sh · $189.27M · Q2 2026
- NVP Associates, LLC 2.14M sh · $125.23M · Q3 2026
- Aaron Wealth Advisors LLC 1.18M sh · $68.92M · Q3 2026
- Kynam Capital Management, LP 934.80K sh · $54.80M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 873.49K sh · $51.20M · Q3 2026
- BRAIDWELL LP 710.88K sh · $39.24M · Q2 2026
- TCG Crossover Management, LLC 650.00K sh · $38.10M · Q3 2026
- Deep Track Capital, LP 640.00K sh · $37.52M · Q3 2026
- Cormorant Asset Management, LP 550.00K sh · $30.36M · Q2 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held MBX?
Parkman Healthcare Partners LLC has disclosed MBX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Parkman Healthcare Partners LLC's current position in MBX?
As of Q3 2026, Parkman Healthcare Partners LLC holds 716.54K shares of MBX (MBX BIOSCIENCES INC), valued at $42.00M, representing 3.79% of its reported portfolio and ranking #3.
Has Parkman Healthcare Partners LLC been buying or selling MBX?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in MBX. The position peaked in Q2 2026 at 800.17K shares.
Which other funds hold MBX?
Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, NEA Management Company, LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.